Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 22, 2020
White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging studyRyo Ochi, Yoshihiro Noda, Shohei Tsuchimoto, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2019
Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy studyRyosuke Tarumi, Sakiko Tsugawa, Yoshihiro Noda, et al.
Psychiatry and Clinical Neurosciences|September 16, 2022
Gamma-aminobutyric acid (GABA) levels in the midcingulate cortex and clozapine response in patients with treatment-resistant schizophrenia: A proton magnetic resonance spectroscopy (<sup>1</sup> H-MRS) studyFumihiko Ueno, Shinichiro Nakajima, Yusuke Iwata, et al.
Molecular Psychiatry|October 14, 2018
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studiesSho Moriguchi, Akihiro Takamiya, Yoshihiro Noda, et al.
Molecular Psychiatry|September 29, 2021
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of <sup>1</sup>H-magnetic resonance spectroscopy studiesTomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry|April 21, 2022
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatmentMasataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
Schizophrenia Research|May 26, 2020
Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation studyTsutomu Takahashi, Sakiko Tsugawa, Shinichiro Nakajima, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 23, 2024
Increased structural covariance of cortical measures in individuals with an at-risk mental stateDaiki Sasabayashi, Sakiko Tsugawa, Shinichiro Nakajima, et al.
JAMA Psychiatry|April 21, 2021
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level DataKate Merritt, Philip K McGuire, Alice Egerton, et al.
Molecular Psychiatry|February 22, 2023
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysisKate Merritt, Robert A McCutcheon, André Aleman, et al.
Pageof 9